IP Library Granted Patent US 7,652,044
Granted Patent B2
US 7,652,044 · App. 10/860,768 · Granted Jan 26, 2010

P-38 inhibitors

Assignee: Novartis A.G.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,652,044
App. No.
10/860,768
Granted
Jan 26, 2010
Kind
B2
Abstract

Provided are 5-membered heterocycle-based p38 kinase, including p38α and p38β kinase, inhibitors. Pharmaceutical compositions containing the compounds are also provided. Methods of use of the compounds and compositions are also provided, including methods of treatment, prevention, or amelioration of one or more symptoms of p38 kinase mediated diseases and disorders, including, but not limited to, inflammatory diseases and disorders.

Claims (162)

1. A method of treating rheumatoid arthritis, comprising administering a compound of formula (I):

or pharmaceutically acceptable derivatives thereof, wherein:

R 1 is hydrogen, methyl, halo, hydroxyl, lower alkyl, lower cycloalkyl, lower alkynyl, trifluoromethyl, methoxy, trifluoromethoxy, cyano, —NH 2 , —NR 4 R 5 or —OR 4 ;

R 2 is attached to any available carbon atom of the phenyl ring A and at each occurrence is independently selected from alkyl, substituted alkyl, lower cycloalkyl, halo, trifluoromethyl, trifluoromethoxy, —OR 4 , —CN, —NR 4 R 5 ; —S(═O)alkyl, —S(═O)aryl, —NHSO 2 -arylene-R 4 , —NHSO 2 alkyl, —CO 2 R 4 , —CONH 2 , —SO 3 H, —S(O)alkyl, —S(O)aryl, —SO 2 NHR 4 , and —NHC(═O)NHR 4 ;

n is 0, 1 or 2;

R 3 is selected from hydrogen, alkyl, —OR 4 , substituted alkyl, cycloalkyl, —CR 4 cycloalkyl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle;

Y is —C(═O)NH—;

Z is NR 4 , S or O;

B is 1,3-thiazole; 1,2,4-triazole; 1,2,4-thiadazole; 1,3-oxazole or 1,2,4-oxadiazole optionally substituted with up to two R 13 ;

Q is independently selected from a single bond, —O—, —S—, —NR 4 —, —S(O)—, —SO 2 —, —C(O)—, —CO(O)—, —C(O)NH—(C 0-4 alkyl)- or —CH 2 —;

D is a monocyclic or bicyclical ring system optionally containing up to four heteroatom's selected from N, O, and S, and wherein a CH 2 adjacent to any of the said N, O or S heteroatoms is optionally substituted with oxo (═O) or D is C 1-6 alkyl, and wherein D is optionally substituted by one to four (CR 9 R 10 ) w E groups;

w is an integer having a value from 0-4;

R 10 is selected from H, C 1 -C 4 alkylhydroxy, C 1 -C 4 alkylaryl and C 1 -C 4 alkylheteroaryl, wherein said aryl or heteroaryl group is unsubstituted or substituted with 1-3 groups independently selected from halo, NO 2 , C 1 -C 4 alkyl, C 3 -C 10 cycloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, haloalkyl, haloalkoxy, OH, C 1 -C 4 alkoxy, C 1 -C 4 alkylcarbonyl, CN, NH 2 , NR 6 R 7 , SR 6 , S(O)R 6 , SO 2 R 6 , SO 3 R 6 , SO 2 NR 6 , CO 2 H, CO 2 R 6 , and CONR 6 R 7 ;

E is selected from H, halogen, NO 2 , C 1 -C 4 alkyl, C 3 -C 10 cycloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, haloalkyl, haloaloxy, OH, OR 6 , CN, CHO, CO 2 R 6 , CONR 8 R 7 , OCOR 6 , OC(═O)OR 6 , OC(═O)NR 6 R 7 , OCH 2 CO 2 R 6 , C(═O)R 6 , NH 2 , NHR 6 , NR 6 R 7 , NR 7 C(═O)R 6 , NR 7 C(═O)OR 6 , NR 7 C(═O)C(═O)OR 6 , NR 7 C(═O)C(═O)NR 6 R 7 , NR 7 C(═O)C(═O)(C 1 -C 6 alkyl), NR 7 C(═NCN)OR 6 , NR 7 C(═O)NR 6 R 7 , NR 7 C(═NCN)NR 6 R 7 , NR 7 C(═NR 6 )NR 7 R 8 , NR 6 SO 2 NR 6 R 7 , NR 7 SO 2 R 6 , SR 6 , S(═O)R 6 , SO 2 R 6 , SO 3 R 7 , SO 2 NR 6 R 7 , NHOH, NHOR 6 , NR 6 NR 7 NR 8 , N(COR 6 )OH, N(CO 2 R 6 )OH, CONR 7 (CR 9 R 10 ) r R 6 , CO(CR 9 R 10 ) p O(CHR 9 ) q CO 2 R 6 , CO(CR 9 CR 10 ) r R 6 , CO(CR 9 R 10 ) p O(CR 9 R 10 ) p O(CHR 9 ) q CO 2 R 6 , CO(CR 9 CR 10 ) r OR 6 , CO(CR 9 R 10 ) p O(CR 9 R 10 ) q R 6 , CO(CR 6 CR 10 ) r NR 6 R 7 , OC(O)O(CR 9 R 10 ) m NR 6 R 7 , O(CO) n (CR 9 R 10 )R 6 , O(CR 9 R 10 ) m NR 6 R 7 m NR 7 C(O)(CR 9 R 10 ) r OR 6 , NR 7 C(═NC)(CR 9 R 10 ) r R 6 , NR 7 CO(CR 9 R 10 ) r NR 6 R 7 , NR 7 (CR 9 R 10 ) m OR 6 , NR 7 (CR 9 R 10 ) r CO 2 R 6 , NR 7 (CR 9 R 10 ) m NR 6 R 7 , NR 7 , NR 3 (CR 9 R 10 ) n SO 2 (CR 9 R 10 ) r CO 2 R 6 , NR 7 (CR 9 R 10 ) m NR 6 R 7 , NR 7 (CR 9 R 10 ) n SO 2 (CR 9 R 10 ) q R 6 , CONR 7 (CR 9 R 10 ) n SO 2 (CR 9 R 10 ) q R 6 , SO 2 NR 7 (CR 9 R 10 ) q R 6 , SO 2 NR 6 (CR 9 R 10 ) m OR 6 , C 2 -C 6 alkenyl, C 3 -C 10 cycloalkyl, C 3 -C 10 cycloalkylmethyl, aryl, heterocyclic optionally substituted with one or two alkyl groups, heteroaryl optionally substituted with one or two alkyl groups and alkylaryl, wherein said aryl groups are unsubstituted or substituted with 1 or 2 substituents each independently selected from R 12 ;

m is an integer having a value from 2-6;

p is an integer having a value from 1-3;

q is an integer having a value from 0-3;

r is an integer having a value from 0-6;

R 12 at each occurrence is independently selected from halo, NO 2 , C 1 -C 4 alkyl, C 3 -C 10 cycloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, haloalkyl, haloalkoxy, OH, oxo, C 1 -C 4 alkoxy, OR 6 , O(CR 9 R 10 )CO 2 R 6 , O(CR 9 R 10 ) m NR 6 R 7 , O(CR 9 R 10 ) p CN, O(CR 9 R 10 ) r C(═O)NR 6 R 7 , C 1 -C 4 alkylcarbonyl, CN, NH 2 , NHR 6 , NR 6 R 7 , NR 7 (CR 9 R 10 )CO 2 R 6 , NR 7 OR 6 , NR 7 (CR 9 R 10 ) m OR 6 , NR 7 CH((CR 9 R 10 ) p OR 6 ) 2 , NR 7 C((CR 9 R 10 ) p OR 6 ) 3 , NR 7 C(═O)R 6 , NR 7 (CR 9 R 10 ) m NR 6 R 7 , NR 7 (CR 9 R 10 ) q R 6 , SR 7 , S(O)R 7 , SO 2 R 7 , SO 2 NR 6 , SO 3 R 7 , CO 2 H, CO 2 R 6 , and CONR 6 R 7 ;

R 4 is hydrogen, lower alkyl and lower cycloalkyl;

R 5 is hydrogen, lower alkyl and lower cycloalkyl;

R 6 , R 7 and R 8 are independently selected as follows:

i) R 6 , R 7 and R 8 are independently selected from H, C 1 -C 6 alkyl, C 3 -C 10 cycloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 alkylcarbonyl, C 3 -C 7 cycloalkyl(C O -C 5 alkyl)carbonyl, C 1 -C 6 alkoxycarbonyl, aryl(C 0 -C 5 alkyl)carbonyl, aryl(C 1 -C 5 alkoxy)carbonyl, heterocyclic(C 0 -C 5 alkyl)carbonyl, heterocyclic(C 1 -C 5 alkoxy)carbonyl, C 1 -C 6 alkylsulfonyl, arylsulfonyl, heteroarylsulfonyl, C 0 -C 4 alkylaryl, C 0 -C 4 alkylheterocyclic, wherein said cycloalkyl, aryl, or heterocyclic groups are unsubstituted or substituted with 1 or 2 substituents each independently selected from the group consisting of C 1 -C 4 alkyl, hydroxyl, C 1 -C 4 alkoxy, F, Cl, Br, haloalkyl, NO 2 and CN; or,

ii) R 6 and R 7 , or R 6 and R 8 , or R 7 and R 8 when both substituents are on the same nitrogen atom (as in (—NR 6 R 7 ) or (—NR 7 R 8 )), can be taken together with the nitrogen atom to which they are attached to form a heterocycle selected from 1-aziridinyl, 1-azetidinyl, 1-piperidinyl, 1-morpholinyl, 1-pyrrolidinyl, thiamorpholinyl, thiazolidinyl, 1-piperazinyl, 1-imidazolyl, 3-azabicyclo(3,2,2)nonan-3yl, and 1-tetrazolyl, the said heterocycle being optionally substituted with 1-3 groups each independently selected from oxo, C 0 -C 4 alkylOH, C 0 -C 4 alkylOC 1 -C 4 alkyl, C 0 -C 4 alkylCONH 2 , C 0 -C 4 alkylCO 2 C 0 -C 4 alkyl, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 3 -C 7 cycloalkyl, C 0 -C 6 alkylcarbonyl, C 3 -C 7 cycloalkylcarbonyl, C 1 -C 6 alkoxycarbonyl, C 3 -C 7 cycloalkoxycarbonyl, —NHCOalkyl, aryl, heteroaryl, arylalkoxycarbonyl, heteroarylalkoxycarbonyl, C 1 -C 6 alkylsulfonyl, arylsulfonyl and heteroarylsulfonyl;

R 9 is hydrogen or C 1 -C 4 alkyl; and

R 13 is hydrogen, alkyl, haloalkyl, aminocarbonyl, hydroxycarbonyl, alkoxycarbonyl, cycloalkylalkylaminocarbonyl, substituted alkyl, aryl, substituted aryl, heteroaryl, heterocyclyl, alkylthio, alkylaminocarbonyl or lower cycloalkyl; where the substituents on alkyl group are selected from one to four substituents selected from halo, hydroxy, alkoxy, oxo (═O), alkanoyl, aryloxy, alkanoyloxy, amino, alkylamino, arylamino, aralkylamino, disubstituted amines in which the 2 amino substituents are selected from alkyl, aryl or aralkyl; alkanoylamino, aroylamino, aralkanoylamino, substituted alkanoylamino, substituted arylamino, substituted aralkanoylamino, thiol, alkylthio, arylthio, aralkylthio, alkyithiono, arylthiono, aralkylthiono, alkylsulfonyl, arylsulfonyl, aralkylsulfonyl, sulfonamido, substituted sulfonamido, nitro, cyano, carboxy, carbamyl, substituted carbamyl, CONHaryl, CONHaralkyl or cases where there are two substituents on the nitrogen selected from alkyl, aryl or aralkyl; alkoxycarbonyl, aryl, substituted aryl, guanidino and substituted or unsubstituted heterocycles, indolyl, imidazolyl, furyl, thienyl, thiazolyl, pyrrolidyl, pyridyl, pyrimidyl and the substituents on aryl group are selected from one to four substituents selected from alkyl, substituted alkyl, haloalkyl, halo, trifluoromethoxy, trifluoromethyl, hydroxy, hydroxyalkyl, aminoalkyl, alkoxy, alkanoyl, alkanoyloxy, amino, arylamino, aralkylamino, dialkylamino, alkanoylamino, thiol, alkylthio, ureido, nitro, cyano, cyanoalkyl, heterocyclyl, carboxy, carboxyalkyl, carbamyl, alkoxycarbonyl, aminocarbonyl, alkylthiono, arylthiono, arylsulfonylamine, sulfonic acid, alkysulfonyl, sulfonamido, aryloxy and CONR a R b , where R a and R b are selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, alkoxycarbonylaminoalkyl and alkylamino; or R a and R b together with the nitrogen on which they are substituted, form a 3-6 membered heterocyclic or heteroaryl ring; the substituent may be further substituted by hydroxy, alkyl, alkoxy, aryl, substituted aryl, substituted alkyl or aralkyl.

2. The method of claim 1 , wherein R 1 is lower alkyl.

3. The method of claim 1 , wherein R 1 is methyl.

4. The method of claim 1 , wherein R 2 is hydrogen or alkyl.

5. The method of claim 1 , wherein R 2 is hydrogen or lower alkyl.

6. The method of claim 1 , wherein R 2 is hydrogen.

7. The method of claim 1 , wherein R 3 is selected from alkyl, —OR 4 , substituted alkyl, cydoalkyl, —CR 4 cycloalkyl, heteroaryl, substituted heteroaryl, heterocycle and substituted heterocycle.

8. The method of claim 1 , wherein R 3 is cycloalkyl, cycloalkylalkyl, alkoxyalkyl or heteroaryl.

9. The method of claim 1 , wherein R 3 is methyl, isopropyl, ethyl, cyclopropyl, cyclopropylmethyl, methoxymethyl, oxazolyl or thiazolyl.

10. The method of claim 1 , wherein B is a 1,3-thiazolyl ring optionally substituted with one or two R 13 .

11. The method of claim 1 , wherein B is a 1,3-thiazolyl ring optionally substituted with one R 13 .

12. The method of claim 1 , wherein Q is a single bond, —CO(O)—, —C(O)— or —C(O)NH—(C 0-4 alkyl)-.

13. The method of any of claim 1 , wherein Q is a single bond.

14. The method of claim 1 , wherein Q is —C(O)—.

15. The method of claim 1 , wherein Q is —CO(O)—.

16. The method of claim 1 , wherein Q is —C(O)NH—(C 0-4 alkyl)-.

17. The method of claim 1 , wherein Q is —C(O)NH— or —C(O)NHCH 2 CH 2 —.

18. The method of claim 1 , wherein Q is —C(O)NH—.

19. The method of claim 1 , wherein D is a monocyclic or bicyclic ring system optionally containing up to four heteroatoms selected from N, O, and S or D is C 1-6 alkyl and wherein D is optionally substituted by one to four (CR 9 R 10 ) w E groups.

20. The method of claim 1 , wherein D is C 1-6 alkyl, alkoxy, cycloalkyl, aryl, arylalkyl, heterocyclyl or heteroaryl ring, wherein the heteroatoms are selected from O, N and S and D is optionally substituted with one to four (CR 9 R 10 ) w E groups.

21. The method of claim 1 , wherein D is selected from methyl, ethyl, propyl, ethoxy cyclopropyl, phenyl, berizyl, berizimidazolyl, piperazinyl, pipendinyl, diazaoxazolyl or pyrimidinyl and D is optionally substituted with one to four (CR 9 R 10 ) w E groups.

22. The method of claim 1 , wherein D is selected from 1-piperazinyl, 4-piperidinyl, 4-pyndinyl, 1,3,4-diazaoxazolyl or 3-pyndinyl, and D is optionally substituted with one or two (CR 9 R 10 ) w E groups.

23. The method of claim 1 , wherein D is phenyl and D is optionally substituted with one or two (CR 9 R 10 ) w E groups.

24. The method of claim 1 , wherein w is 1.

25. The method of claim 1 , wherein w is 0.

26. The method of claim 1 , wherein D is substituted with one to four substituents selected from halo, alkyl, nitro, alkoxy, alkoxycarbonylalkoxy, alkoxyamidoalkylamido, hydroxycarbonyl, alkoxycarbonyl, alkylaminocarbonyl, alkylcarbonylamino, aryl, heteroaryl containing 1 to 3 heteroatoms and optionally substituted with one or two alkyl groups, and heterocyclyl containing 1 to 3 heteroatoms and optionally substituted with two or more alkyl or alkoxycarbonyl groups.

27. The method of claim 1 , wherein D is substituted with one to four substituents selected from chloro, fluoro, methyl, methoxy, ethoxy, methylaminocarbonyl, methoxycarbonylamino, tertbutyloxyamidoethylamido, methoxycarbonyl or phenyl.

28. The method of claim 1 , wherein D is substituted with a heterocyclyl ring selected from morpholinyl or piperidinyl, where the heterocyclyl ring is further substituted with one or two methyl or methoxycarbonyl groups.

29. The method of claim 1 , wherein D is substituted with heteroaryl ring selected from isoxazolyl, furyl, benzimidazolyl and thiazolyl, where the heteroaryl ring is further substituted with one or two methyl groups.

30. The method of claim 1 , wherein D is substituted with N-morpholinyl, pipendin-4-yl or 1-methoxycarbonylpiperidin-4-yl.

31. The method of claim 1 , wherein D is substituted with 2-benzimidazolyl, 3,5-dimethylisoxazol-4-yl, 5-methylisoxazol-3-yl or 2-methylthiazol-5-yl.

32. The method of claim 1 , wherein D is selected from methyl, ethyl, propyl, isopropyl, hydroxycarbonylmethyl, methylaminocarbonylmethyl, ethoxycarbonylpropyl, ethoxycarbonylmethyl, phenyl, fluorophenyl, tolyl, methoxyphenyl, methoxycarbonylmethoxy, ethoxy, benzimidazolyl, methylpiperazinyl, piperidinyl, 1,3,4-diazaoxazolyl, morpholin-1-ylphenyl, piperidin-4-ylphenyl, 1methoxycarbonylpiperidin-4-ylphenyl, benzyl, chiorophenyl, methylcarbonylaminophenyl, bromophenyl, carboxymethyl, tertbutyloxyamidoethylamidophenyl, methylaminocarbonylmethyl, N-methoxycarbonylpiperidinyl, piperidinyl, pyridinyl, cyclopropyl, dimethylisoxazolylmethyl, methylisoxazolylmethyl and methylthiazolylmethyl.

33. The method of claim 1 , wherein D is selected from methyl, ethyl, propyl, isopropyl, cydopropylmethyl, hydroxycarbonylmethyl, ethoxycarbonylpropyl, methylaminocarbonylmethyl, ethoxycarbonylmethyl, phenyl, 4-fluorophenyl, p-tolyl, 4-methoxyphenyl, 4-methoxycarbonylmethoxyphenyl, ethoxy, 2-benzimidazolylmethyl, 4-methylpiperazin-1-yl, 1,3,4-diazaoxazolyl, 4-piperidinyl, benzyl, 4-chlorophenyl, 4-morpholin-1-ylphenyl, 4-(piperidin-4-yl)phenyl. 4-(1-methoxycarbonylpiperidin-4-yl)phenyl, 4-ethoxycarbonylmethoxyphenyl, 4-methylamidophenyl, and 4-tertbutyloxyamidoethylamidophenyl.

34. The method of claim 1 , wherein R 13 is selected from methyl, trifluoromethyl, tert-butyl, amido, methoxycarbonyl, carboxyl, ethoxycarbonyl, cyclopropyimethyiaminocarbonyl, thienyl, methylenedioxybenzyl, ethylenedioxybenzyl, pyridinyl, and phenyl; and R 13 is optionally substituted with one or more R 14 , where R 14 is hydrogen, chloro, fluoro, hydroxy, methyl, cyano, amino, aminoethyl, N-morpholinyl, methylsulfonylamino, tertbutoxyamidomethylamido, tertbutoxyamidoethylamidophenyl, aminomethylamido, methoxycarbonylpiperazinyl, methylcarbonyl, methoxy, ethoxy, methoxycarbonyl, trifluoromethyl, hydroxymethyl, amido, aminomethyl, carboxy, tertbutoxyamidoethylamido, aminoethylamido, methylsulfonyl, N-morpholinocarbonyl, cyclopropylamido, ethylthio, carboxymethoxy, N-morpholinoethoxy, aminoethoxy, ethylamido, n-butoxy, aminopropyloxy or carboxymethoxy.

35. The method of claim 1 , wherein R 13 is selected from methyl, trifluoromethyl, tert-butyl, amido, methoxycarbonyl, carboxyl, ethoxycarbonyl, cyclopropylmethylaminocarbonyl, thienyl, methylenedioxybenzyl, ethylenedioxybenzyl, 4-cyanomethylphenyl, 4-cyanophenyl, 2-chlorophenyl, 4-hydroxyphenyl, m-tolyl, 3-fluorophenyl, p-tolyl, 3-cyanophenyl, 5-methylcarbonylthien-2-yl, 5-cyanothien-2-yl, 4-methoxyphenyl, 4-methoxycarbonylphenyl, 4-fluorophenyl, 2-methoxyphenyl, 2-trifluoromethylphenyl, 4-hydroxymethylphenyl, 3-aminocarbonylphenyl, 4-aminocarbonylphenyl, 3-aminomethylphenyl, 3-carboxyphenyl, 4-carboxyphenyl, o-tolyl, 2,4-difluorophenyl, 3-aminoethylaminocarbonylphenyl, 4-aminoethylaminocarbonylphenyl, 3-aminomethylaminocarbonylphenyl, 4-aminomethylaminocarbonylphenyl, 4methylsulfonylphenyl, 4-(N-morpholino)carbonylphenyl, 4-ethoxy-3-fluorophenyl, 3-cyclopropylamidophenyl, 3-ethoxyptienyl, 4-ethylthiophenyl, 4-methoxy-3-fluorophenyl, 4-fluoro-3-methylphenyl, 3,4-difluorophenyl, 3-methyl-4-methoxyphenyl, 3-hydroxycarbonylmethoxyphenyl, 4-(N-morpholino)ethoxyphenyl, 4-hydroxyphenyl, phenyl, 3-aminoethoxyphenyl, 4-ethylaminocarbonylphenyl, 4-n-butoxyphenyl, 3-methyl4-methoxyphenyl, 3-aminopropyloxyphenyl 4-cyanomethylphenyl, 4-aminophenyl, 3-aminophenyl, 4-aminoethylphenyl, 4-morpholin-1-ylphenyl, 4-methylsulfonylaminophenyl, 3-tertbutoxyarnidomethylamidophenyl, 4-tertbutoxyamidomethylamidophenyl, 3-tertbutoxyamidoethylamidophenyl, 4-tertbutoxyamidoethylamidopheflyl, 3-aminomethylamidophenyl, 4-(methoxycarbonylpiperazin-1-yl)phenyl and 2-rnethoxypyrimidin-3-yl.

36. The method of claim 1 , wherein the compound is of formula (I-1):

37. The method of claim 1 , wherein the compound is of formula (I-2):

where X 1 is selected from O, S and optionally substituted N, where the substituent on the N when present is selected from hydrogen, alkyl, substitued alkyl, alkenyl or alkynyl and X 2 is S or O.

38. The method of claim 1 , wherein the compound is of formula (I-3):

39. The method of claim 1 , wherein the compound is of formula (I-4):

40. The method of claim 1 , wherein the compound is of formula (I-5):

where n 1 is 0-5.

41. The method of claim 1 , wherein the compound is of formula (I-6):

where n 3 is 1-4.

42. The method of claim 1 , wherein the compound is of formula (I-7):

where n 2 is 0-4.

43. The method of claim 1 , wherein the compound is of formula (I-8):

44. The method of claim 1 , wherein the compound is of formula (I-9):

45. The method of claim 1 , wherein the compound is of any of formulae (I-10):

46. The method of claim 1 , wherein the compound is selected from:

N-methoxy-4-methyl-3-(5-phenyl-4H-[1,2,4]triazol-3-ylamino)-benzamide;

N-methoxy-4-methyl-3-(5-phenyl-[1,2,4]oxadiazol-3-ylamino)-benzamide;

N-Cyclopropyl-4-methyl-3-(4-phenyl-thiazol-2-ylamino)-benzamide;

3-[4-(4-Cyano-phenyl)-thiazol-2-ylamino]-N-cyclopropyl-4-methyl-benzamide;

N-Cyclopropyl-3-[4-(4-fluoro-phenyl)-thiazol-2-ylamino]-4-methyl-benzamide;

N-Cyclopropyl-3-[4-(4-methoxy-phenyl)-thiazol-2-ylamino]-4-methyl-benzamide;

N-Cyclopropyl-3-[4-(3-methoxy-phenyl)-thiazol-2-ylamino]-4-methyl-benzamide;

N-Cyclopropyl-3-[4-(2-methoxy-phenyl)-thiazol-2-ylamino]-4-methyl-benzamide;

N-Cyclopropyl-4-methyl-3-(5-methyl-4-phenyl-thiazol-2-ylamino)-benzamide;

2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-thiazole-4-carboxylic acid phenylamide;

N-Isopropyl-4-methyl-3-(4-phenyl-thiazol-2-ylamino)-benzamide;

N-Ethyl-4-methyl-3-(4-phenyl-thiazol-2-ylamino)-benzamide;

N-(2-Methoxy-ethyl)-4-methyl-3-(4-phenyl-thiazol-2-ylamino)-benzamide;

4-Methyl-3-(4-phenyl-thiazol-2-ylamino)-I-thiazol-2-yl-benzamide;

4-Methyl-3-(4-phenyl-thiazol-2-ylamino)-N-[1,2,4]triazol-4-yl-benzamide;

4-Methyl-N-(5-methyl-[1,3,4]thiadiazol-2-yl)-3-(4-phenyl-thiazol-2-ylamino)-benzamide;

N-Cyclopropyl-4-methyl-3-(5-phenyl-oxazol-2-ylamino)-benzamide;

N-Cyclopropyl-4-methyl-3-(5-phenyl-4H-[1,2,4]triazol-3-ylamino)-benzamide;

N-Cyclopropyl-4-methyl-3-(5-phenyl-[1,2,4]oxadiazol-3-ylamino)-benzamide;

N-Cyclopropyl-4-methyl-3-(5-phenyl-[1,3,4]thiadiazol-2-ylamino)-benzamide;

N-Cyclopropyl-4-methyl-3-(3-phenyl-[1,2,4]thiadiazol-5-ylamino)-benzamide;

2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-4-methyl-thiazole-5-carboxylic acid benzyl ester;

2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-4-methyl-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-thiazole-4-carboxylic acid ethyl ester;

5-Bromo-2-(5-cyclopropylcarbamoyl-2-methyl-phenylamino)-thiazole-4-carboxylic acid ethyl ester;

2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-4-(4-nitro-phenyl)-thiazole-5-carboxylic acid ethyl ester;

N-Cyclopropyl-4-methyl-3-[4-(4-nitro-phenyl)-thiazol-2-ylamino]-benzamide;

3-[5-Bromo-4-(4-nitro-phenyl)-thiazol-2-yiamino]-N-cyclopropyl-4-methyl-benzamide;

2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-4-(4-morpholin-4-yl-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-thiazole-5-carboxylic acid methyl ester;

2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-4-phenyl-thiazole-5-carboxylic acid cyclopropylmethyl-amide;

4-{3-[2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-5-methoxycarbonyl-thiazol-4-yl]-phenyl}-piperidine-1-carboxylic acid methyl ester;

4-{3-[2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-5-(cyclopropylmethyl-carbamoyl)-thiazol-4-yl]-phenyl}-piperidine-1-carboxylic acid methyl ester;

4-{3-[2-(5-cyclopropylcarbamoyl-2-methyl-phenylamino)-5-[1,3,4]oxadiazol-2-yl-thiazol-4-yl]-phenyl}-piperidinium trifluoroacetate;

N-Cyclopropyl-4-methyl-3-[4-(4-nitro-phenyl)-5-[1,3,4]oxadiazol-2-yl-thiazol-2-ylamino]benzamide;

2-(5-Cyclopropylcarbamoyl-2-methyl-phenylamino)-thiazole-5-carboxylic acid benzylamide; 4-Bromo-2-(5-cyclopropylcarbamoyl-2-methyl-phenylamino)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cycloproplcarbamoyl-2-methyl-phenylamino)-4-(4-fluoro-3-methyl-phenyl)-thiazole-5-carboxylic acid benzylamide;

4-(4-Cyanomethyl-phenyl)-2-(5-cyclo-propylcarbamoyl-2-methylphenylamino)-thiazole-5-carboxylic acid benzylamide;

4-(4-Cyano-phenyl)-2-(5cyclopropyl-carbamoyl-2-methyl-phenylamino)-4,5-dihydro-thiazole-5-carboxylic acid benzylamide;

4-(2-Chloro-phenyl)-2-(5-cyclopropyl-carbamoyl-2-methyl-phenylamino)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropyl-carbamoyl-2-methyl-phenylamino)-4-(3-hydroxymethylphen-yl)-thiazole-5-carbox-ylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-m-tolyl-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(3-fluorophenyl)thia-zole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-p-tolyl-thiazole-5-carboxylic acid benzylamide;

4-(3Cyano-phenyl)-2-(5-cyclopropyl-carbamoyl-2-methyl-phenylamino)thia-zole-5-carboxylic acid benzylamide;

4-(5-Acetyl-thiophen-2-yl)-2-(5-cyclo-propylcarbamoyl-2-methylphenylamino)-thiazole-5-carboxylic acid benzylamide;

4-Benzo[1,3]dioxol-5-yl-2-(5-cycloprop-ylcarbamoyl-2-methylphenylamino)-thiazole-5-carboxylic acid benzylamide;

4-(5-Cyano-thiophen-2-yl)-2-(5-cycloprop-ylcarbamoyl-2-methylphenylamino)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(4-methoxy-phenyl)-thiazole-5-carboxylic acid benzylamide;

4-[5-Benzylcarbamo-yl-2-(5-cyclopropyl-carbamoyl-2-methyl-phenylamino)thiaz-ol-4-yl]benzoic acid ethyl ester;

3-[5-Benzylcarbamo-yl-2-(5-cyclopropyl-carbamoyl-2-methyl-phenylamino)thiaz-ol-4-yl]-benzoic acid methyl ester;

2-(5-Cyclopropyl-carbamoyl-2-methyl-phenyiamino)-4-(4-fluoro-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropyl-carbamoyl2-methyl-phenylamino)-4-(2-methoxy-phenyl)thiazole-5-carboxlic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino-4-(3-methoxy-phenyl)thiazol-5-carboxlic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(2-trifluoromethyl-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(4-hydroxymethyl-phenyl)-thiazole-5-carboxylic acid benzylamide;

4-(3-Carbamoylphen-yl)-2-(5-cyclopropyl-carbamoyl-2-methyl-phenylamino)-thiazole-5-carboxylic acid benzylamide;

4-(4-Carbamoyl-phenyl)-2-(5-cyclo-propylcarbamoyl-2-methylphenylamino)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(2,3-dihydrobenzo[1,4]di-oxin-6-yl)-thiazole-5-carboxylic acid benzylamide;

4-(3-Aminomethyl-phenyl)-2-(5-cyclo-propylcarbamoyl-2-methylphenylamino)-thiazole-5-carboxylic acid benzylamide;

3-[5-Benzylcarbamo-yl-2-(5-cyclopropyl-carbamoyl-2-methyl-phenylamino)-thiaz-ol-4-yl]-benzoic acid;

4-[5-Benzylcarbamo-yl-2-(5-cyclopropyl-carbamoyl-2-methyl-phenylamino)thiazol-4-yl]-benzoic acid;

2-(5-Cyclopropyl-bamoyl-2-methyl-phenylamino)-4-o-tolyl-thiazole-5-car-boxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(2,4-difluoro-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(4-methanesulfonyl-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-[4-(morpholine-4-carbonyl)-phenyl]-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(4-ethoxy-3-fluoro-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(3-cyclopropylcarbamoyl-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(3-ethoxy-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(4-ethylsulfanyl-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(3-fluoro-4-methoxy-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(4-fluoro-3-methoxy-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(3,4-difluoro-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(2-fluoro-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(4-ethoxy-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(1H-indol-5-yl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(4-methoxy-3-methyl-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(4-ethylcarbamoyl-phenyl)-thiazole-5-carboxylic acid benzylamide;

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(4-hydroxy-phenyl)-thiazole-5-carboxylic acid benzylamide,

2-(5-Cyclopropylcar-bamoyl-2-methyl-phenylamino)-4-(4-propoxy-phenyl)-thiazole-5-carboxylic acid benzylamide;

4-(4-Amino-phenyl)-2-(5-cyclopropylcarbamoyl-2-methyl-phenylamino)-thiazole-5-carboxylic acid benzylamide;

4-(3-Amino-phenyl)-2-(5-cyclopropylcarbamoyl-2-methyl-phenylamino)-thiazole-5-carboxylic acid benzylamide;

4-[3-(3-Amino-propionylamino)-phenyl]-2-(5-cyclopropylcarbamoyl-2-methyl-phenylamino)-thiazole-5-carboxylic acid benzylamide ditrifluoroacetate;

4-[4-(2-Amino-acetylamino)-phenyl]2-(5-cyclopropylcarbamoyl-2-methyl-phenylamino)-thiazole-5-carboxylic acid benzylamide ditrifluoroacetate;

2-{4-[5-benzylcarbamoyl-2-(5-cyclopropylcarbamoyl-2-methyl-phenylamino)-thiazo-4-yl]-phenylcarbamoyl}-ethyl-ammonium ditrifluoroacetate;

4-(4-Cyanomethyl-phenyl)-2-(5-cyclopropytcarbamoyl-2-methyl-phenylamino)-thiazole-5-carboxylic acid benzylamide; and

4-[4-(2-Amino-ethyl)-phenyl]-2-(5-cyclopropylcarbamoyl-2-methyl-phenylamino)-thiaxzole-5-carboxytic acid benzylamide.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2006
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 017225/0548 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2005
From: TRIAD THERAPEUTICS, INC.
To: NOVARTIS PHARMA AG
Reel/Frame 016215/0026 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2004
From: DONG, QING; PIERRE, FABRICE; WANG, JIANQIANG
To: TRIAD THERAPEUTICS, INC.
Reel/Frame 015055/0435 →
Continuity (3)
Provisional Application 6047566200 · Jun 3, 2003
Provisional Application 6053154100 · Dec 19, 2003
Related Publication 20040254236A1 · Dec 16, 2004